As we age, our risk for serious illnesses like cancer, heart disease, and dementia increases. Traditionally, scientists have focused on treating these diseases one by one. However, there’s a new idea taking shape: what if we could slow down aging itself to reduce the overall risk of these diseases? To explore this, researchers need to understand the biological changes that aging brings.
A recent study published in Science sheds light on this topic. Scientists at The Rockefeller University created a detailed map of how aging affects various cell types in different organs. They examined nearly 7 million individual cells from mice at three stages of life: young adults, middle-aged, and elderly. This research helps identify which cells are most vulnerable as we age and what may cause their decline.
“Our goal was to understand not just what changes with aging, but why,” explains Junyue Cao, who leads the research. By looking at cellular and molecular changes together, they hope to pinpoint what drives aging and, eventually, find ways to intervene.
One of the most exciting discoveries was that many age-related changes happen simultaneously across organs. Interestingly, nearly half of these changes differed between males and females. For instance, female mice showed broader immune system changes as they aged. This could help explain why women are more prone to autoimmune diseases.
To create their aging map, the team improved a method called single-cell ATAC-seq. This technique reveals how DNA is packed in cells, which shows which parts of the genome are active—key information for understanding a cell’s state.
The researchers studied cells from 21 organs in 32 mice across three age groups. Remarkably, one graduate student managed to generate this extensive atlas—a feat that typically requires many labs working together.
They identified over 1,800 different cell types, some of which had never been described before. As the mice aged, significant changes were noted in the number of certain cells. Contrary to previous beliefs that aging mainly affects how cells function, this study reveals that the number of cells also changes significantly—about 25% of all cell types showed notable shifts over time.
Cao remarks, “The system is far more dynamic than we realized.” Some cell populations, like certain muscle and kidney cells, declined noticeably by middle age. This suggests that aging is not just a late-life event but part of ongoing development.
Moreover, the synchronized changes point to possible shared signals in the bloodstream that coordinate aging across different organs. This observation could lead researchers to new pathways for potential treatments.
The study further highlighted strong gender differences. About 40% of the changes linked to aging varied by sex, revealing a deeper layer of complexity in the aging process.
Additionally, the research analyzed how DNA accessibility changed in the cells over time. Among 1.3 million regions examined, about 300,000 exhibited significant aging-related changes. Many of these areas related to immune function and inflammation, pointing to specific “hotspots” that are particularly vulnerable during aging.
“This challenges the idea that aging is just random genomic decay,” Cao asserts. These hotspots might be critical for understanding the aging process and developing new therapies. Research suggests that drugs targeting immune signaling molecules could slow down the aging process across multiple organs.
This pioneering work sets the stage for future studies. Researchers are now focusing on whether they can actively target these aging processes. As we continue to learn about the intricate details of aging, there’s hope that we can develop methods to enhance longevity and overall health.
If you’re interested in exploring this groundbreaking research further, you can find the full aging atlas available at epiage.net.
Source link
Kidney Disease; Heart Disease; Healthy Aging; Stem Cells; New Species; Mice; Biotechnology and Bioengineering; Biotechnology
